INBX logo

Inhibrx Biosciences, Inc. (INBX) Free Cash Flow

Annual FCF:

-$197.01M+$896.00K(+0.45%)
December 31, 2024

Summary

  • As of today, INBX annual free cash flow is -$197.01 million, with the most recent change of +$896.00 thousand (+0.45%) on December 31, 2024.
  • During the last 3 years, INBX annual free cash flow has fallen by -$115.82 million (-142.66%).
  • INBX annual free cash flow is now -880.52% below its all-time high of -$20.09 million, reached on December 31, 2017.

Performance

INBX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXcash flow metrics

Quarterly FCF:

-$33.83M-$3.88M(-12.96%)
September 30, 2025

Summary

  • As of today, INBX quarterly free cash flow is -$33.83 million, with the most recent change of -$3.88 million (-12.96%) on September 30, 2025.
  • Over the past year, INBX quarterly free cash flow has dropped by -$3.31 million (-10.83%).
  • INBX quarterly free cash flow is now -2179.92% below its all-time high of -$1.48 million, reached on September 30, 2019.

Performance

INBX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXcash flow metrics

TTM FCF:

-$143.44M-$3.31M(-2.36%)
September 30, 2025

Summary

  • As of today, INBX TTM free cash flow is -$143.44 million, with the most recent change of -$3.31 million (-2.36%) on September 30, 2025.
  • Over the past year, INBX TTM free cash flow has increased by +$9.83 million (+6.41%).
  • INBX TTM free cash flow is now -6452.72% below its all-time high of -$2.19 million, reached on March 31, 2018.

Performance

INBX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

INBX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+0.5%-10.8%+6.4%
3Y3 Years-142.7%-9.8%-32.8%
5Y5 Years-481.3%-138.6%-214.5%

INBX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-142.7%+0.5%-13.0%+47.3%-34.3%+27.2%
5Y5-Year-481.3%+0.5%-144.4%+47.3%-214.5%+27.2%
All-TimeAll-Time-880.5%+0.5%-2179.9%+47.3%-6452.7%+27.2%

INBX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$33.83M(-13.0%)
-$143.44M(-2.4%)
Jun 2025
-
-$29.95M(+16.6%)
-$140.13M(+17.0%)
Mar 2025
-
-$35.92M(+17.9%)
-$168.75M(+14.3%)
Dec 2024
-$197.01M(+0.5%)
-$43.74M(-43.3%)
-$197.01M(-28.5%)
Sep 2024
-
-$30.53M(+47.9%)
-$153.27M(-24.9%)
Jun 2024
-
-$58.57M(+8.7%)
-$122.74M(-14.9%)
Mar 2024
-
-$64.17M(-50.6%)
-$106.78M(+26.0%)
Dec 2023
-$197.90M(-116.3%)
-
-
Jun 2023
-
-$42.62M(-6.6%)
-$144.27M(-11.9%)
Mar 2023
-
-$39.97M(-29.5%)
-$128.90M(-11.1%)
Dec 2022
-$91.50M(-12.7%)
-$30.87M(-0.2%)
-$115.99M(-7.4%)
Sep 2022
-
-$30.82M(-13.1%)
-$108.01M(-18.6%)
Jun 2022
-
-$27.24M(-0.7%)
-$91.03M(-5.1%)
Mar 2022
-
-$27.06M(-18.2%)
-$86.58M(-6.6%)
Dec 2021
-$81.19M
-$22.89M(-65.3%)
-$81.19M(-9.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$13.84M(+39.3%)
-$74.30M(+0.5%)
Jun 2021
-
-$22.79M(-5.2%)
-$74.64M(-17.5%)
Mar 2021
-
-$21.66M(-35.4%)
-$63.52M(-28.8%)
Dec 2020
-$49.33M(-45.6%)
-$16.00M(-12.8%)
-$49.33M(-8.2%)
Sep 2020
-
-$14.18M(-21.5%)
-$45.61M(-38.6%)
Jun 2020
-
-$11.67M(-56.1%)
-$32.91M(+7.8%)
Mar 2020
-
-$7.48M(+39.1%)
-$35.71M(-5.4%)
Dec 2019
-$33.89M(-38.2%)
-$12.28M(-727.3%)
-$33.89M(-56.8%)
Sep 2019
-
-$1.48M(+89.7%)
-$21.61M(-7.4%)
Jun 2019
-
-$14.47M(-156.0%)
-$20.13M(-5.0%)
Mar 2019
-
-$5.65M(+58.2%)
-$19.17M(-22.1%)
Dec 2018
-$24.52M(-22.0%)
-
-
Jun 2018
-
-$13.52M(-517.5%)
-$15.71M(-617.5%)
Mar 2018
-
-$2.19M
-$2.19M
Dec 2017
-$20.09M
-
-

FAQ

  • What is Inhibrx Biosciences, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. annual free cash flow year-on-year change?
  • What is Inhibrx Biosciences, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. quarterly free cash flow year-on-year change?
  • What is Inhibrx Biosciences, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. TTM free cash flow year-on-year change?

What is Inhibrx Biosciences, Inc. annual free cash flow?

The current annual free cash flow of INBX is -$197.01M

What is the all-time high annual free cash flow for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high annual free cash flow is -$20.09M

What is Inhibrx Biosciences, Inc. annual free cash flow year-on-year change?

Over the past year, INBX annual free cash flow has changed by +$896.00K (+0.45%)

What is Inhibrx Biosciences, Inc. quarterly free cash flow?

The current quarterly free cash flow of INBX is -$33.83M

What is the all-time high quarterly free cash flow for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high quarterly free cash flow is -$1.48M

What is Inhibrx Biosciences, Inc. quarterly free cash flow year-on-year change?

Over the past year, INBX quarterly free cash flow has changed by -$3.31M (-10.83%)

What is Inhibrx Biosciences, Inc. TTM free cash flow?

The current TTM free cash flow of INBX is -$143.44M

What is the all-time high TTM free cash flow for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high TTM free cash flow is -$2.19M

What is Inhibrx Biosciences, Inc. TTM free cash flow year-on-year change?

Over the past year, INBX TTM free cash flow has changed by +$9.83M (+6.41%)
On this page